United States Antimony Corporation reported second-quarter revenue of $7.9 million [1], triggering a 14% decline in pre-market share prices [9].
The results highlight the company's vulnerability to volatile commodity markets, as a sharp drop in antimony prices offset growth in other business segments.
Revenue for the quarter fell approximately 25% year-over-year [2], according to some reports, while others cited a decline of 24.7% [10]. This figure fell significantly short of the consensus revenue estimate of $21.7 million [6], representing a revenue surprise of -47.51% [8]. Despite the annual drop, the company saw a 17% increase in revenue sequentially from the first quarter [3].
The antimony segment, a core part of the business, generated $5.9 million [4]. Management said the financial impact of the antimony price collapse during an Aug. 18 earnings call [12].
However, the company found a bright spot in its zeolite operations. Zeolite sales experienced a 110% surge [11] during the period. This growth suggests a diversifying revenue stream as the company navigates the instability of the antimony market.
Financial performance regarding earnings per share remained mixed. While the consensus estimate for the quarter was $0.02 [5], some reports indicated the company delivered break-even earnings, roughly $0.00 per share [13]. This discrepancy resulted in a reported earnings surprise of +100.00% [7].
Executives said updates on government contracts and current operating results during the recorded webcast and conference call [12]. The call focused on the balance between the struggling antimony market and the rapid expansion of zeolite product sales.
“United States Antimony reported second-quarter revenue of $7.9 million.”
The disparity between the company's zeolite growth and its antimony losses indicates a strategic pivot or a necessary reliance on secondary products to survive commodity price volatility. While the 110% jump in zeolite sales is a positive indicator of market demand, it is currently insufficient to compensate for the massive revenue miss relative to analyst expectations, leaving the stock susceptible to further volatility.
